Under the FDA’s current rules, some cereals and snacks are deemed healthier than fruits and nuts based on fat content. That is likely to change as the agency plans to modernize the definition of ‘healthy’ to keep up with changing eating habits in the U.S.
The next generation of senior citizens will be sicker and costlier to the health care system over the next 14 years than previous generations, according to a new report from the United Health Foundation. We’re talking about you, baby boomers.
The nation was enjoying its breakfast last week when the latest food fight broke out. A damning report by a leading obesity charity warned that the low-fat, low-cholesterol message underpinning 30 years of public health advice was plain wrong.
The lipid theory of heart disease, linking saturated fat to coronary heart disease, continues to crumble. Of course there never was any real solid science linking traditional saturated fats and cholesterol to heart disease, but that didn’t stop the pharmaceutical companies from making billions of dollars from the sale of cholesterol-lowering drugs. Before the patent expired, Lipitor was the best selling drug of all time, nearly equalling the sales of all other drugs combined.
Members of campaign group to disown controversial guidelines to eat fats and cut down on carbohydrates.
Britain’s leading anti-obesity campaign group is in turmoil after its controversial new dietary advice provoked serious infighting and threats by leading doctors to shun it over its “misleading” views.
Privately, the National Obesity Forum (NOF) is in disarray over recommendations last week that people should eat more fat, reduce carbohydrates and stop counting calories.
Professor Tim Noakes discusses the challenges of LCHF leadership. Stemming the tide of Diabesity…through the appliance of correct science. Recorded at the May 2016 Foodloose Iceland event (Harpa Conference Centre, Reykjavik).
Carbohydrate restriction may be effective in ameliorating adverse effects associated with androgen-deprivation therapy (ADT) for prostate cancer, according to study findings presented at the American Urological Association annual meeting.